Xconomy: Agenda: What's Hot in Boston Biotech


	4.06.2016	AGENDA
		.
	12:30 – 1:30	Registration & Networking
	1:30 – 1:45	Welcome & Opening Remarks Al Sandrock, Chief Medical Officer, Biogen Bob Buderi, Founder, CEO, and Editor in Chief, Xconomy
	1:45 – 2:15	Neoantigens and the Next Wave of Cancer Vaccines Cary Pfeffer, Partner, Third Rock Ventures Nir Hacohen, Co-founder, Neon Therapeutics; Director, MGH Center for Immunotherapy Samantha Singer, COO, The Broad Institute (moderator)
	2:15 – 2:30	Spotlight Talk: Biotech Game Theory Peter Kolchinsky, Founder & Managing Director, RA Capital
	2:30 – 3:00	Innovative Approaches to Neuroscience Deborah Dunsire, CEO, Forum Pharmaceuticals Al Sandrock, Chief Medical Officer, Biogen Daphne Zohar, CEO, PureTech Health Jens Eckstein, President, SR One (moderator)
	3:00 – 3:30	Networking Break
	3:30 – 4:00	NASH and Nimbus: Combating the Looming Liver Disease Epidemic Bruce Booth, Partner, Atlas Venture Don Nicholson, CEO, Nimbus Therapeutics
	4:00 – 4:15	Spotlight Talk: The Druggability Gap Gregory Verdine, Founder & CSO, Warp Drive Bio; Professor, Harvard University
	4:15 – 4:45	Biology Meets Engineering Phillip A. Sharp, Nobel Laureate; Institute Professor, MIT Robert Urban, Head, Johnson & Johnson Innovation, Boston (moderator)
	4:45 – 5:15	Drug Pricing and Innovation: Combating Healthcare’s Biggest Challenge Peter Hecht, CEO, Ironwood Pharmaceuticals Tillman U. Gerngross, Professor of Bioengineering, Dartmouth College Marc Rubenstein, Partner, Ropes & Gray (moderator)
	5:15 – 6:30	Networking Reception

*Schedule is subject to change.

Join us on April 6, register now.